adenosine has been researched along with B16 Melanoma in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (6.67) | 18.7374 |
1990's | 3 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 9 (60.00) | 24.3611 |
2020's | 2 (13.33) | 2.80 |
Authors | Studies |
---|---|
Bussolari, JC; Chen, SF; Panzica, RP; Ramesh, K; Stoeckler, JD | 1 |
Ahmad, S; Amaya, L; Broughton, JP; Cadena, C; Chang, HY; Chen, R; Chen, YG; Hur, S; Kasturi, SP; Kim, J; Pulendran, B; Verma, R | 1 |
Ding, X; Li, D; Peng, Y; Wang, X; Wang, Y; Wu, Y; Yang, A; Yang, P; Yin, H; Yu, Y; Zhang, J; Zhang, R; Zhang, X | 1 |
Bissonnette, MB; Chang, R; Chen, C; Dong, L; Dougherty, U; Guo, P; Han, D; Lai, W; Li, J; Li, Y; Liang, G; Liu, J; Liu, Y; Shen, L; Sun, M; Wang, H; Wang, Z; Xu, MM; Zhang, Y | 1 |
Bezuhly, M; Gebremeskel, S; Johnston, B; LeVatte, T; Liwski, RS | 1 |
Alexander, MP; Chabanet, TB; Clancy-Thompson, E; Croteau, W; Huang, YH; Mullins, DW; Perekslis, TJ; Turk, MJ | 1 |
Arredondo, S; Bono, MR; Fernández, D; Flores-Santibáñez, F; Guixé, V; Meza, D; Rosemblatt, M; Sauma, D; Tejón, G; Varela-Nallar, L; Vargas, L | 1 |
Bigda, J; Gołuńska, M; Koszałka, P; Majewski, M; Składanowski, AC; Stanisławowski, M; Stasiłojć, G; Urban, A | 1 |
Adcock, IM; Arra, C; Luciano, A; Maiolino, P; Montinaro, A; Morello, S; Ngkelo, A; Pinto, A; Sorrentino, R | 1 |
Curiel, TJ; Fan, J; Shin, T; Thompson, LF; Wang, L; Zhang, B; Zhang, Y | 1 |
Korenstein, R; Madi, L; Nyska, A; Rosenberg-Haggen, B | 1 |
Sadej, R; Skladanowski, AC | 1 |
Amanatullah, DF; Clair, T; Liotta, LA; Schetz, JA; Stracke, ML; Woodhouse, EC | 1 |
Liteplo, RG | 1 |
Akedo, H; Horai, T; Inoue, H; Mukai, M; Nishikawa, S; Ohigashi, H; Shinkai, K; Takeda, Y | 1 |
15 other study(ies) available for adenosine and B16 Melanoma
Article | Year |
---|---|
Synthesis and biological evaluation of N4-substituted imidazo- and v-triazolo[4,5-d]pyridazine nucleosides.
Topics: Adenosine Deaminase Inhibitors; Animals; Antineoplastic Agents; Cattle; Humans; Leukemia L1210; Melanoma, Experimental; Mice; Nucleosides; Pyridazines; Structure-Activity Relationship; Tumor Cells, Cultured | 1993 |
N6-Methyladenosine Modification Controls Circular RNA Immunity.
Topics: Adaptor Proteins, Signal Transducing; Adenosine; Adjuvants, Immunologic; Animals; CD8-Positive T-Lymphocytes; DEAD Box Protein 58; Female; HEK293 Cells; HeLa Cells; Humans; Immunity, Innate; Immunization; Interferon Regulatory Factor-3; Interferons; Lymphocytes, Tumor-Infiltrating; Melanoma, Experimental; Mice, Inbred C57BL; Polyubiquitin; Protein Multimerization; Receptors, Immunologic; RNA-Binding Proteins; RNA, Circular; Ubiquitination | 2019 |
RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming.
Topics: Adenosine; Animals; Base Sequence; Cell Line, Tumor; Cell Polarity; Cell Proliferation; Cellular Reprogramming; Cytokines; Gene Deletion; Gene Expression Regulation; Lung Neoplasms; Macrophages; Melanoma, Experimental; Methylation; Methyltransferases; Mice, Knockout; Myeloid Cells; Neoplasm Metastasis; NF-kappa B; Programmed Cell Death 1 Receptor; Repressor Proteins; RNA-Binding Proteins; RNA, Neoplasm; STAT3 Transcription Factor; T-Lymphocytes, Regulatory; Tumor Microenvironment | 2021 |
The loss of RNA N
Topics: Adenosine; Animals; Carcinoma, Lewis Lung; CD8-Positive T-Lymphocytes; Colorectal Neoplasms; Cytokines; Female; Humans; Lymphocyte Activation; Melanoma, Experimental; Methyltransferases; Mice; Mice, Inbred C57BL; Mice, Knockout; Minor Histocompatibility Antigens; Neoplasms; Receptors, Cytokine; Tumor Microenvironment; Tumor-Associated Macrophages | 2021 |
The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer.
Topics: Adenosine; Animals; Antineoplastic Agents; Bone Neoplasms; Drug Screening Assays, Antitumor; Female; Gene Expression; Liver Neoplasms; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Transplantation; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticagrelor | 2015 |
Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease.
Topics: Adenosine; Animals; CD8-Positive T-Lymphocytes; Chemokines; Cytokines; Disease Models, Animal; Humans; Ligands; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Melanoma; Melanoma, Experimental; Mice, Knockout; Neoplasm Metastasis; Receptors, CXCR3; Signal Transduction; T-Lymphocytes; Tumor Burden | 2015 |
CD73-mediated adenosine production promotes stem cell-like properties in mouse Tc17 cells.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Adoptive Transfer; Animals; CD8-Positive T-Lymphocytes; Cell Differentiation; Cytokines; Down-Regulation; Immunologic Memory; Immunophenotyping; Lymphocytes, Tumor-Infiltrating; Melanoma, Experimental; Mice; Mice, Transgenic; Phenotype; Stem Cells; T-Lymphocyte Subsets | 2015 |
Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration.
Topics: 5'-Nucleotidase; Adenosine; Animals; Cell Proliferation; Extracellular Space; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Macrophages; Male; Melanoma, Experimental; Mice; Neovascularization, Pathologic; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Signal Transduction; Up-Regulation | 2016 |
NK1.1 cells and CD8 T cells mediate the antitumor activity of Cl-IB-MECA in a mouse melanoma model.
Topics: Adenosine; Animals; Antimetabolites, Antineoplastic; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Chemotaxis, Leukocyte; Female; Immunity, Cellular; Killer Cells, Natural; Lymphocyte Activation; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Skin Neoplasms; Tumor Microenvironment | 2011 |
CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Animals; Chemotaxis, Leukocyte; Disease Progression; Female; Immunotherapy, Adoptive; Lymphocytes, Tumor-Infiltrating; Lymphoma, Non-Hodgkin; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Molecular Targeted Therapy; Ovarian Neoplasms; Peritoneal Neoplasms; Radiation Chimera; Second Messenger Systems; T-Lymphocytes; T-Lymphocytes, Regulatory; Tumor Burden | 2011 |
Enhancing pigmentation via activation of A3 adenosine receptors in B16 melanoma cells and in human skin explants.
Topics: Adenosine; Androstadienes; Cell Line, Tumor; Cyclic AMP; Dihydroxyphenylalanine; Humans; In Vitro Techniques; Keratinocytes; MAP Kinase Signaling System; Melanoma, Experimental; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Phosphatidylinositol 3-Kinases; Phosphorylation; Pigmentation; Protein Kinase Inhibitors; Protein Transport; Proto-Oncogene Proteins c-akt; Receptor, Adenosine A3; Skin; Skin Neoplasms; Wortmannin | 2013 |
Dual, enzymatic and non-enzymatic, function of ecto-5'-nucleotidase (eN, CD73) in migration and invasion of A375 melanoma cells.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Cell Adhesion; Cell Line, Tumor; Cell Movement; Concanavalin A; Extracellular Matrix; Humans; Melanoma, Experimental; Neoplasm Invasiveness; Tenascin | 2012 |
Adenosine receptor mediates motility in human melanoma cells.
Topics: Adenosine; Adenosine Monophosphate; Animals; Chemotaxis; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Humans; Melanoma, Experimental; Pertussis Toxin; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Transfection; Virulence Factors, Bordetella; Xanthines | 1998 |
Reversion to a homocysteine-responsive phenotype in a human melanoma cell line is associated with diminished growth potential and increased methionine biosynthesis.
Topics: Adenosine; Cell Division; Culture Media; Deoxyadenosines; Homocysteine; Humans; Melanoma, Experimental; Methionine; Phenotype; S-Adenosylmethionine; Tetrahydrofolates; Thionucleosides; Tumor Cells, Cultured | 1990 |
Inhibition of in vitro tumor cell invasion by transmethylation inhibitors.
Topics: Adenosine; Animals; Antineoplastic Agents; Carcinoma, Small Cell; Deoxyadenosines; Fibrosarcoma; Humans; Kinetics; Liver Neoplasms, Experimental; Lung Neoplasms; Melanoma, Experimental; Methylation; Neoplasm Invasiveness; Rats; Rats, Inbred Strains; Thionucleosides; Tumor Cells, Cultured | 1989 |